Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1 Breast 1

Conditions

Breast Neoplasms 84 Neoplasm Metastasis 8 Neoplasms 6 Sarcoma 4 Squamous Cell Carcinoma of Head and Neck 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Squamous Cell 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Untreated Operable Early Breast Cancer 1 Triple Negative Breast Neoplasms 1 Testicular Neoplasms 1 Teratoma 1 Somatostatinoma 1 Solid Tumors 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrent Squamous Cell Lung Carcinoma 1 Rectal Neoplasms 1

Interventions

Letrozole 3 Fulvestrant 3 exemestane 2 Trastuzumab 2 Irinotecan 2 Docetaxel 2 Capecitabine 2 Anastrozole 2 ribociclib 1 palbociclib 1 irinotecan sucrosofate 1 abemaciclib 1 Rogaratinib 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Liposomes 1 Everolimus 1 Cyclophosphamide 1 Cell Separation 1 Aromatase Inhibitors 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Breast Cancer Metastatic × palbociclib × Clear all

NCT04483505 2023-12-28

ROGABREAST

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 1 Completed

BreastOther neoplasm

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡